Delivery Order SPE2DR25D3012-SPE2DR26F4D8M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used for surgical hemostasis. This firm fixed-price delivery order, valued at $1,094.80, represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The order...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical and wound care applications. The contract, valued at $6,283.48, is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025. This non-set-aside award was competitively procured and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery...
- The Department of Defense Medical Supply Chain awarded a $27,136.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical and trauma settings. This non-competitive delivery order, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom on June 2, 2025, with a ceiling value of $28,940.39. This firm fixed-price delivery order, with an ultimate completion date of June 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made without a set-aside designation through competitive procurement, and performance will...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $18,783.90 firm fixed price delivery order for 20,000 units of RECOTHROM, a thrombin-based hemostatic agent used in surgical settings to control bleeding. This non-set-aside competitive award was issued on December 11, 2025, with an ultimate completion date of January 9, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $11,306.34, was competitively awarded with an ultimate completion date of December 17, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 5,000 unit vials of Recothrom, a pharmaceutical product used in surgical hemostasis. This firm fixed-price delivery order, valued at $2,567.33, was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 23, 2025, by the Defense Logistics Agency Medical Supply Chain to supply 20,000 unit vials of RECOTHROM (thrombin topical) with a ceiling value of $9,422.34. This non-competitive, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is set to be completed by July 24,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for 20,000 unit vials of Recothrom (thrombin topical), a hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $7,567.75, was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of RECOTHROM under a firm fixed-price contract with a ceiling value of $1,696.32. The order, which was not set-aside designated and competitively awarded, was executed on June 25, 2025, with an ultimate completion date of June 26, 2025. Performance will take place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4D8MDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,746.32 for 20,000 unit vials of Recothrom on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, leverages this comprehensive IDC vehicle to supply a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The SPE2DX contract serves as a global pharmaceutical support mechanism enabling the company to fulfill orders for specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Recothrom, a thrombin-based hemostatic agent used in surgical applications, exemplifies the vendor's role in providing critical medical products through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/18/25 |